PARAGON 28 INC.  DL-,01

PARAGON 28 INC. DL-,01

Aktie · US69913P1057 · FNA · A3C5FT (XNYS)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu PARAGON 28 INC. DL-,01
Analyst Grade Summary
gauge-img
Halten
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
3
4
0
0
Kein Kurs
ESG-Risiko-Rating
B Gering
Free Float & Liquidität
Free Float 52,64 %
Shares Float 44,19 M
Ausstehende Aktien 83,94 M
Firmenprofil zu PARAGON 28 INC. DL-,01 Aktie
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Unternehmensdaten

Name PARAGON 28 INC. DL-,01
Firma Paragon 28, Inc.
Symbol FNA
Website https://www.paragon28.com
Heimatbörse XNYS Frankfurt
WKN A3C5FT
ISIN US69913P1057
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Albert DaCosta
Marktkapitalisierung 1 Mrd.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,5 T
Adresse 14445 Grasslands Drive, 80112 Englewood
IPO Datum 2021-10-15

Ticker Symbole

Name Symbol
Frankfurt 7GQ.F
NYSE FNA
Weitere Aktien
Investoren, die PARAGON 28 INC. DL-,01 halten, haben auch folgende Aktien im Depot:
INTEL CORP 16/26
INTEL CORP 16/26 Anleihe
SCHMITT INDUSTRIES INC
SCHMITT INDUSTRIES INC Aktie